Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

Details for Australian Patent Application No. 2005255013 (hide)

Owner Avanir Pharmaceuticals

Inventors Nikoulin, Igor; Alisala, Kashinatham; Sircar, Jagadish C.; Vassar, Victor Charles

Agent Davies Collison Cave

Pub. Number AU-A-2005255013

PCT Pub. Number WO2005/123770

Priority 60/578,226 09.06.04 US; 60/667,368 01.04.05 US

Filing date 9 June 2005

Wipo publication date 29 December 2005

International Classifications

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123770 Priority application(s): WO2005/123770

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005255019-Compositions and methods for diagnosis and treatment of orthopoxviruses

2005255012-Small molecules for treatment of hypercholesterolemia and related diseases